These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 33321450)
21. External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort. Tilki D; Mandel P; Schlomm T; Chun FK; Tennstedt P; Pehrke D; Haese A; Huland H; Graefen M; Salomon G J Urol; 2015 Jun; 193(6):1970-5. PubMed ID: 25498570 [TBL] [Abstract][Full Text] [Related]
22. A novel nomogram provides improved accuracy for predicting biochemical recurrence after radical prostatectomy. Xia HZ; Bi H; Yan Y; Yang B; Ma RZ; He W; Zhu XH; Zhang ZY; Zhang YT; Ma LL; Hou XF; Wirth GJ; Lu J Chin Med J (Engl); 2021 Jun; 134(13):1576-1583. PubMed ID: 34133352 [TBL] [Abstract][Full Text] [Related]
23. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men. Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959 [TBL] [Abstract][Full Text] [Related]
24. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748 [TBL] [Abstract][Full Text] [Related]
25. Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging. Chang K; Greenberg SA; Cowan JE; Parker R; Shee K; Washington SL; Nguyen HG; Shinohara K; Carroll PR; Cooperberg MR J Urol; 2023 Aug; 210(2):281-289. PubMed ID: 37099018 [TBL] [Abstract][Full Text] [Related]
26. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy. Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777 [TBL] [Abstract][Full Text] [Related]
27. Prediction model for early biochemical recurrence after radical prostatectomy based on the Cancer of the Prostate Risk Assessment score and the presence of secondary circulating prostate cells. Murray NP; Aedo S; Reyes E; Orellana N; Fuentealba C; Jacob O BJU Int; 2016 Oct; 118(4):556-62. PubMed ID: 26507242 [TBL] [Abstract][Full Text] [Related]
28. Prostate Surface Distension and Tumor Texture Descriptors From Pre-Treatment MRI Are Associated With Biochemical Recurrence Following Radical Prostatectomy: Preliminary Findings. Shiradkar R; Ghose S; Mahran A; Li L; Hubbard I; Fu P; Tirumani SH; Ponsky L; Purysko A; Madabhushi A Front Oncol; 2022; 12():841801. PubMed ID: 35669420 [TBL] [Abstract][Full Text] [Related]
29. Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance. Kim HL; Li P; Huang HC; Deheshi S; Marti T; Knudsen B; Abou-Ouf H; Alam R; Lotan TL; Lam LLC; du Plessis M; Davicioni E; Fleshner N; Lane BR; Ross AE; Davis JW; Mohler JL; Trock BJ; Klein EA; Tosoian JJ; Hyndman ME; Bismar TA Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):399-405. PubMed ID: 30542054 [TBL] [Abstract][Full Text] [Related]
30. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies. Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844 [TBL] [Abstract][Full Text] [Related]
31. The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy. Morlacco A; Sharma V; Viers BR; Rangel LJ; Carlson RE; Froemming AT; Karnes RJ Eur Urol; 2017 May; 71(5):701-704. PubMed ID: 27576750 [TBL] [Abstract][Full Text] [Related]
32. External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score. Zhao KH; Hernandez DJ; Han M; Humphreys EB; Mangold LA; Partin AW Urology; 2008 Aug; 72(2):396-400. PubMed ID: 18372031 [TBL] [Abstract][Full Text] [Related]
33. Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients. Budäus L; Isbarn H; Tennstedt P; Salomon G; Schlomm T; Steuber T; Haese A; Chun F; Fisch M; Michl U; Heinzer H; Huland H; Graefen M BJU Int; 2012 Dec; 110(11):1714-20. PubMed ID: 22520619 [TBL] [Abstract][Full Text] [Related]
34. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. Cooperberg MR; Broering JM; Carroll PR J Natl Cancer Inst; 2009 Jun; 101(12):878-87. PubMed ID: 19509351 [TBL] [Abstract][Full Text] [Related]
35. Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy. Zanelli E; Giannarini G; Cereser L; Zuiani C; Como G; Pizzolitto S; Crestani A; Valotto C; Ficarra V; Girometti R J Magn Reson Imaging; 2019 Nov; 50(5):1604-1613. PubMed ID: 30957321 [TBL] [Abstract][Full Text] [Related]
36. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cooperberg MR; Freedland SJ; Pasta DJ; Elkin EP; Presti JC; Amling CL; Terris MK; Aronson WJ; Kane CJ; Carroll PR Cancer; 2006 Nov; 107(10):2384-91. PubMed ID: 17039503 [TBL] [Abstract][Full Text] [Related]
37. Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy. Ho R; Siddiqui MM; George AK; Frye T; Kilchevsky A; Fascelli M; Shakir NA; Chelluri R; Abboud SF; Walton-Diaz A; Sankineni S; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA PLoS One; 2016; 11(6):e0157313. PubMed ID: 27336392 [TBL] [Abstract][Full Text] [Related]
38. Genetic predisposition to early recurrence in clinically localized prostate cancer. Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk. Ross AE; Den RB; Yousefi K; Trock BJ; Tosoian J; Davicioni E; Thompson DJ; Choeurng V; Haddad Z; Tran PT; Trabulsi EJ; Gomella LG; Lallas CD; Abdollah F; Feng FY; Klein EA; Dicker AP; Freedland SJ; Karnes RJ; Schaeffer EM Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):277-82. PubMed ID: 27136742 [TBL] [Abstract][Full Text] [Related]
40. Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): ability to predict cancer progression and decision-making regarding adjuvant therapy after radical prostatectomy. Seo WI; Kang PM; Kang DI; Yoon JH; Kim W; Chung JI J Korean Med Sci; 2014 Sep; 29(9):1212-6. PubMed ID: 25246738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]